A prestigious £600,000 grant will help academics at The University of Nottingham to cross the research ‘valley of death’ to bring the latest advances from bench to bedside.
The University will use the Confidence in Concept award from the Medical Research Council to fund a number of six to 12-month feasibility studies to develop new drugs and diagnostic technologies.
The funded projects will fall into three broad categories — biomedical markers and diagnostics; biomedical imaging; and drug discovery, development and delivery — and will be aimed at bringing developments out of the lab and translating them into real advances in patient care.
The latest grant brings the total the University has received from the Confidence in Concept programme to £1 million, having previously received a £400,000 grant in 2012.
Professor Saul Tendler, Pro-Vice-Chancellor for Research, said: “We are delighted to have been recognised again by the MRC in these awards. This grant will fund projects developing interventions which would represent a step change improvement in the treatment and diagnosis of serious disease.
“The Confidence in Concept award is particularly aimed at research which has the potential to have a huge impact on patient care but which may struggle to cross the so-called ‘valley of death’ — the funding divide between the initial breakthrough stage and clinical trial which can often be a significant financial barrier to bringing new treatments and technologies to the market.”
It is hoped that the initial grant from this project will allow researchers to produce a robust ‘proof of concept’ that will attract additional support from other funding bodies to take the research further.
The first tranche of cash from the Confidence in Concept programme has already gone on to support projects including roadtesting a more reliable MRI test for multiple sclerosis that works across all MRI scanners; improved diagnostics for gastric conditions such as dyspepsia, reflux disease and diabetic gastro paresis and new tests to detect Parkinson’s disease in its earliest stages.
Researchers at the University will be invited to bid for the latest pot of funding and the successful projects are likely to be announced in the spring this year.
— Ends —
Our academics can now be interviewed for broadcast via our new Globelynx fixed camera facility at the University. For further information please contact a member of the Communications team on +44 (0)115 951 5798, email firstname.lastname@example.org or see the Globelynx website for how to register for this service.
For up to the minute media alerts follow us on Twitter
Notes to editors: The University of Nottinghamhas 43,000 students and is ‘the nearest Britain has to a truly global university, with campuses in China and Malaysia modelled on a headquarters that is among the most attractive in Britain’ (Times Good University Guide 2014). It is also the most popular university among graduate employers, the world’s greenest university, and winner of the Times Higher Education Award for ‘Outstanding Contribution to Sustainable Development’. It is ranked in the World's Top 75 universities by the QS World University Rankings.
Impact: The Nottingham Campaign, its biggest-ever fundraising campaign, is delivering the University’s vision to change lives, tackle global issues and shape the future. More news…